Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01376349 | Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms | completed | Phase 3 | 464 | Alliance for Clinical Trials in OncologyOTHER | 1 | Feb 7, 2019 | clinicaltrials |
| NCT01633060 | A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi(BELLE-3) | terminated | Phase 3 | 432 | Novartis PharmaceuticalsINDUSTRY | 22 |
| Jan 30, 2019 |
| clinicaltrials |
| NCT03240224 | Bioinformation Therapy for Breast Cancer | completed | Phase 2 / Phase 3 | 120 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT00513292 | Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery | completed | Phase 3 | 280 | National Cancer Institute (NCI)NIH | 2 | Jan 23, 2019 | clinicaltrials |
| NCT02187744 | A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04) | completed | Phase 3 | 226 | PfizerINDUSTRY | 10 | Jan 8, 2019 | clinicaltrials |
| NCT00876395 | Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer(BOLERO-1) | completed | Phase 3 | 719 | Novartis PharmaceuticalsINDUSTRY | 28 | Dec 19, 2018 | clinicaltrials |
| NCT01073865 | Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer | completed | Phase 3 | 222 | AstraZenecaINDUSTRY | 6 | Dec 12, 2018 | clinicaltrials |
| NCT02751606 | Nano MRI on 7 Tesla in Rectal and Breast Cancer | unknown | Phase 3 | 30 | Radboud University Medical CenterOTHER | 1 | Dec 6, 2018 | clinicaltrials |
| NCT01764022 | A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients | completed | Phase 3 | 225 | BiocadINDUSTRY | 4 | Nov 29, 2018 | clinicaltrials |
| NCT00046865 | Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer | completed | Phase 3 | 57 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT00869206 | Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement | completed | Phase 3 | 1,822 | Alliance for Clinical Trials in OncologyOTHER | 2 | Nov 7, 2018 | clinicaltrials |
| NCT00002836 | Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer | completed | Phase 3 | 184 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 6, 2018 | clinicaltrials |
| NCT03731026 | The LightPath® and 68Ga-RM2 in Breast Cancer Study | unknown | Phase 3 | 80 | Lightpoint Medical LimitedINDUSTRY | 1 | Nov 6, 2018 | clinicaltrials |
| NCT00089661 | AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer | completed | Phase 3 | 252 | AmgenINDUSTRY | 0 | Oct 17, 2018 | clinicaltrials |
| NCT00793962 | A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer | completed | Phase 3 | 810 | Chinese Academy of Medical SciencesOTHER | 1 | Oct 11, 2018 | clinicaltrials |
| NCT03696004 | Outcome of Neo-adjuvant Chemotherapy Followed by Breast Conservative Surgery in Breast Cancer in Upper Egypt | unknown | Phase 2 / Phase 3 | 45 | Assiut UniversityOTHER | 1 | Oct 4, 2018 | clinicaltrials |
| NCT00639106 | Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial | completed | Phase 3 | 70 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 3, 2018 | clinicaltrials |
| NCT00053898 | Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy | completed | Phase 3 | 3,104 | NSABP Foundation IncNETWORK | 3 | Sep 20, 2018 | clinicaltrials |
| NCT00193726 | Estrogen Priming to Increase the Efficacy of Adjuvant Chemotherapy in Operable Breast Cancer | terminated | Phase 3 | 273 | Sudeep GuptaOTHER_GOV | 1 | Sep 20, 2018 | clinicaltrials |
| NCT01638247 | Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients(MALE) | completed | Phase 3 | 56 | GBG Forschungs GmbHOTHER | 1 | Sep 19, 2018 | clinicaltrials |
| NCT01104571 | Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer(EPHOS-B) | unknown | Phase 3 | 257 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 17, 2018 | clinicaltrials |
| NCT02019277 | A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer(SAPPHIRE) | completed | Phase 3 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Sep 13, 2018 | clinicaltrials |
| NCT02225470 | Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes | completed | Phase 3 | 530 | Eisai Co., Ltd.INDUSTRY | 1 | Aug 28, 2018 | clinicaltrials |
| NCT01035268 | Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment Sequella(GRATSEC) | terminated | Phase 3 | 196 | Institut Claudius RegaudOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT01026142 | A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA) | completed | Phase 3 | 452 | Hoffmann-La RocheINDUSTRY | 23 | Aug 14, 2018 | clinicaltrials |
| NCT01942980 | Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast Cancer | completed | Phase 3 | 8 | Institut Paoli-CalmettesOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00002942 | Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer | completed | Phase 3 | 136 | Wake Forest University Health SciencesOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery(TACT2) | unknown | Phase 3 | 4,400 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT02898376 | Clinical Benefit of Spa Care on Severe Radiation-induced Fibrosis After Postoperative Radiotherapy for Breast Cancer(FIBROTHERME) | unknown | Phase 3 | 142 | Institut de Cancérologie de LorraineOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT03606369 | Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. | unknown | Phase 2 / Phase 3 | 560 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT03561740 | A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients(SMART) | recruiting | Phase 3 | 794 | Sun Yat-sen UniversityOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT00169104 | Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function | terminated | Phase 2 / Phase 3 | 23 | Dartmouth-Hitchcock Medical CenterOTHER | 0 | Jul 20, 2018 | clinicaltrials |
| NCT03566394 | Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy | unknown | Phase 2 / Phase 3 | 46 | British Columbia Cancer AgencyOTHER | 0 | Jun 25, 2018 | clinicaltrials |
| NCT00195013 | Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy | completed | Phase 3 | 30 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT03518957 | 12-week Exercise Intervention Program Versus Observation in Early Stage Breast Cancer Patients on the Impact on Mental Health, Quality of Life and Immune Markers | unknown | Phase 3 | 304 | National University Hospital, SingaporeOTHER | 1 | May 14, 2018 | clinicaltrials |
| NCT03507465 | Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer | unknown | Phase 2 / Phase 3 | 290 | Guangdong Provincial People's HospitalOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT02279108 | Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer(FLUOTECH) | completed | Phase 3 | 99 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Apr 9, 2018 | clinicaltrials |
| NCT03491410 | Breast Cancer Active Surveillance, Alternative Option, Aspirin Included | unknown | Phase 2 / Phase 3 | 60 | Centro Hospitalar Lisboa OcidentalOTHER_GOV | 0 | Apr 9, 2018 | clinicaltrials |
| NCT00689156 | Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer(READ) | completed | Phase 3 | 2,015 | Danish Breast Cancer Cooperative GroupOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT01668914 | Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Positive(IMSLNB-CANP) | completed | Phase 3 | 126 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT01796444 | Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node(Z0011-China) | withdrawn | Phase 3 | 0 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT02269696 | The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients | withdrawn | Phase 3 | 0 | Kuopio University HospitalOTHER | 0 | Mar 22, 2018 | clinicaltrials |
| NCT00338286 | A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy | completed | Phase 3 | 2,098 | Janssen Research & Development, LLCINDUSTRY | 21 | Mar 19, 2018 | clinicaltrials |
| NCT03081234 | Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer(EarLEE-2) | withdrawn | Phase 3 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Mar 15, 2018 | clinicaltrials |
| NCT01792999 | Koning Breast CT for Breast Imaging in China | completed | Phase 3 | 418 | Koning (Tianjin) Medical Equipment Co., LtdINDUSTRY | 1 | Mar 7, 2018 | clinicaltrials |
| NCT03202446 | Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer | terminated | Phase 3 | 18 | Eske Corporation S.A.CINDUSTRY | 1 | Feb 23, 2018 | clinicaltrials |
| NCT03423849 | The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy | unknown | Phase 2 / Phase 3 | 200 | Zhiyong YuOTHER | 0 | Feb 6, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Feb 7, 2019source: clinicaltrials